1. Legionella pneumophila S1P-lyase targets host sphingolipid metabolism and restrains autophagy
- Author
-
Tamara Nora, Malcolm J. McConville, Thierry Levade, Patrice Codogno, Thusitha Rupasinghe, Gilu Abraham, Pedro Escoll, Valérie Boitez, Charlotte Christophe, Dedreia Tull, Alexei Savchenko, Sze Ying Ong, Craig Daniels, Joëlle Botti, Christel Cazalet, Tatiana Skarina, Carmen Buchrieser, Elizabeth L. Hartland, Hubert Hilbi, Monica Rolando, Thomas Naderer, Peter J. Stogios, Delphine Dervins-Ravault, Carmen Bedia, Biologie des Bactéries intracellulaires - Biology of Intracellular Bacteria, Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), Régulations des réactions immunitaires et inflammatoires, Université Nice Sophia Antipolis (... - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-IFR50-Institut National de la Santé et de la Recherche Médicale (INSERM), Glycobiologie et signalisation cellulaire, Université Paris-Sud - Paris 11 (UP11)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut de médecine moléculaire de Rangueil (I2MR), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-IFR150-Institut National de la Santé et de la Recherche Médicale (INSERM), Department of Chemical Engineering and Applied Chemistry (CHEM ENG), University of Toronto, Max Von Pettenkofer Institute (MVP), Ludwig-Maximilians-Universität München (LMU), University of Melbourne, Department of Microbiology and Immunology, Institut Necker Enfants-Malades (INEM - UM 111 (UMR 8253 / U1151)), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre de Recherches en Cancérologie de Toulouse (CRCT), Centre National de la Recherche Scientifique (CNRS)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM), Conseil de la Region Ile-de-France, Fondation pour la Recherche Medicale [ANR-10-INSB-04-01], Institut Pasteur, Domaine d'Interet Majeur Malinf Grant [ANR-10-LABX-62-IBEID], US Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357], INSERM, Infect-European Research Area (ERA) project EUGENPATH [ANR-13-IFEC-0003-02], Fondation pour la Recherche Medicale (FRM) Grant [DEQ20120323697], Agencia de Gestio d'Ajuts Universitaris i Recerca, Generalitat de Catalunya, University of Zurich, Swiss National Science Foundation [31003A\₁53200], Bundesministerium fur Bildung und Forschung (Infect-ERA project EUGENPATH) [031A410A], National Institutes of Health [GM074942, GM094585], Biologie des Bactéries intracellulaires, Institut Pasteur [Paris]-Centre National de la Recherche Scientifique ( CNRS ), Université Nice Sophia Antipolis ( UNS ), Université Côte d'Azur ( UCA ) -Université Côte d'Azur ( UCA ) -IFR50-Institut National de la Santé et de la Recherche Médicale ( INSERM ), Université Paris-Sud - Paris 11 ( UP11 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), Institut de médecine moléculaire de Rangueil ( I2MR ), Université Toulouse III - Paul Sabatier ( UPS ), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-IFR150-Institut National de la Santé et de la Recherche Médicale ( INSERM ), Department of Chemical Engineering and Applied Chemistry ( CHEM ENG ), Max Von Pettenkofer Institute ( MVP ), Ludwig-Maximilians-Universität München, Department of Biochemistry and Molecular Biology, Institut Necker Enfants-Malades (INEM) ( INEM - UM 111 (UMR 8253 / U1151) ), Université Paris Descartes - Paris 5 ( UPD5 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ), Centre de Recherche en Cancérologie de Toulouse ( CRCT ), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ), Buchrieser, Carmen, Université Côte d'Azur (UCA)-Université Côte d'Azur (UCA)-IFR50-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), Université Nice Sophia Antipolis (1965 - 2019) (UNS), Université de Toulouse (UT)-Université de Toulouse (UT)- Institut Fédératif de Recherche Bio-médicale Institution (IFR150)-Institut National de la Santé et de la Recherche Médicale (INSERM), and Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)
- Subjects
0301 basic medicine ,autophagy ,Protein Conformation ,610 Medicine & health ,Crystallography, X-Ray ,Legionella pneumophila ,Microbiology ,Mice ,03 medical and health sciences ,chemistry.chemical_compound ,Catalytic Domain ,Animals ,[SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology ,Secretion ,[ SDV.BBM ] Life Sciences [q-bio]/Biochemistry, Molecular Biology ,Aldehyde-Lyases ,1000 Multidisciplinary ,sphingolipids ,Multidisciplinary ,Innate immune system ,030102 biochemistry & molecular biology ,Sphingosine ,biology ,10179 Institute of Medical Microbiology ,Effector ,Intracellular parasite ,Autophagy ,Biological Sciences ,biology.organism_classification ,Sphingolipid ,sphingosine-1-phosphate lyase ,Cell biology ,virulence ,030104 developmental biology ,chemistry ,570 Life sciences ,Legionnaires' Disease - Abstract
International audience; Autophagy is an essential component of innate immunity, enabling the detection and elimination of intracellular pathogens. Legionella pneumophila, an intracellular pathogen that can cause a severe pneumonia in humans, is able to modulate autophagy through the action of effector proteins that are translocated into the host cell by the pathogen's Dot/Icm type IV secretion system. Many of these effectors share structural and sequence similarity with eukaryotic proteins. Indeed, phylogenetic analyses have indicated their acquisition by horizontal gene transfer from a eukaryotic host. Here we report that L. pneumophila translocates the effector protein sphingosine-1 phosphate lyase (LpSpl) to target the host sphingosine biosynthesis and to curtail autophagy. Our structural characterization of LpSpl and its comparison with human SPL reveals high structural conservation, thus supporting prior phylogenetic analysis. We show that LpSpl possesses S1P lyase activity that was abrogated by mutation of the catalytic site residues. L. pneumophila triggers the reduction of several sphingolipids critical for macrophage function in an LpSpl-dependent and -independent manner. LpSpl activity alone was sufficient to prevent an increase in sphingosine levels in infected host cells and to inhibit autophagy during macrophage infection. LpSpl was required for efficient infection of A/J mice, highlighting an important virulence role for this effector. Thus, we have uncovered a previously unidentified mechanism used by intracellular pathogens to inhibit autophagy, namely the disruption of host sphingolipid biosynthesis.
- Published
- 2016